Skip to main content
SpringerLink
Log in

Terazosin: a single drug for hypertension and BPH symptoms

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

A single drug can be used to manage both hypertension and prostatic obstructive symptoms related to benign prostatic hyperplasia (BPH), common problems in older men. Results of a clinical trial showing the efficacy of this monotherapy approach were presented at the 8th Scientific Meeting of the American Society of Hypertension, held in New York, US, in May.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Jill Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stein, J. Terazosin: a single drug for hypertension and BPH symptoms. Inpharma Wkly. 896, 17 (1993). https://doi.org/10.2165/00128413-199308960-00041

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199308960-00041

Search

Navigation